Prometheus Biosciences Inc. (RXDX) NASDAQ
$199.92 0.18 (0.09%)
Market Cap: -
As of 06/15/23 04:00 PM EDT. Market closed.
Prometheus Biosciences Inc. (RXDX)
NASDAQ
$199.92
0.18 (0.09%)
Market Cap: -
As of 06/15/23 04:00 PM EDT. Market closed.
Add to Portfolio
prometheus biosciences, inc., is a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune ... read more
prometheus biosciences, inc., is a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Mark C. McKenna
Full Time Employees
72
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Mark C. McKenna
Full Time Employees
72
Address
3050 Science Park Road, CA, San Diego, 92121.
PRICE CHART FOR PROMETHEUS BIOSCIENCES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$199.74
Days Range
$199.60 - $199.98
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
47,813,238
Open
-
Previous Close
$199.74
Days Range
$199.60 - $199.98
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
47,813,238
FINANCIAL STATEMENTS FOR PROMETHEUS BIOSCIENCES INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR PROMETHEUS BIOSCIENCES INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| McKenna Mark C. | Chairman, President & CEO | Jun 02, 2023 | Option Exercise | $2.90 | 122,531 | 355,336 | 178,036 | Jun 02, 2023, 07:13 PM |
| Marshall Keith W | Chief Financial Officer | Jun 02, 2023 | Option Exercise | $3.10 | 78,162 | 242,302 | 87,973 | Jun 02, 2023, 07:03 PM |
| Marshall Keith W | Chief Financial Officer | Apr 05, 2023 | Option Exercise | $3.70 | 10,000 | 37,000 | 19,811 | Apr 07, 2023, 09:02 PM |
| Marshall Keith W | Chief Financial Officer | Apr 05, 2023 | Sale | $108.42 | 10,000 | 1,084,200 | 9,811 | Apr 07, 2023, 09:02 PM |
| McKenna Mark C. | Chairman, President & CEO | Mar 15, 2023 | Option Exercise | $2.90 | 25,000 | 72,500 | 80,144 | Mar 17, 2023, 09:02 PM |
| McKenna Mark C. | Chairman, President & CEO | Mar 15, 2023 | Sale | $116.14 | 25,000 | 2,903,500 | 55,144 | Mar 17, 2023, 09:02 PM |
| Marshall Keith W | Chief Financial Officer | Mar 06, 2023 | Option Exercise | $3.70 | 10,000 | 37,000 | 19,811 | Mar 08, 2023, 09:33 PM |
| Marshall Keith W | Chief Financial Officer | Mar 06, 2023 | Sale | $122.13 | 10,000 | 1,221,300 | 9,811 | Mar 08, 2023, 09:33 PM |
| Cedars Sinai Intellectual Property Co | 10% Owner | Mar 08, 2023 | Sale | $114.59 | 865,000 | 99,120,347 | 4,001,132 | Mar 08, 2023, 09:30 PM |
| McKenna Mark C. | Chairman, President & CEO | Mar 03, 2023 | Option Exercise | $3.70 | 10,620 | 39,294 | 65,764 | Mar 03, 2023, 09:30 PM |
| McKenna Mark C. | Chairman, President & CEO | Mar 01, 2023 | Option Exercise | $3.70 | 700 | 2,590 | 55,844 | Mar 03, 2023, 09:30 PM |
| McKenna Mark C. | Chairman, President & CEO | Mar 03, 2023 | Sale | $125.13 | 10,620 | 1,328,881 | 55,144 | Mar 03, 2023, 09:30 PM |
| McKenna Mark C. | Chairman, President & CEO | Mar 01, 2023 | Sale | $125.26 | 700 | 87,682 | 55,144 | Mar 03, 2023, 09:30 PM |
| Marshall Keith W | Chief Financial Officer | Feb 15, 2023 | Option Exercise | $3.70 | 5,000 | 18,500 | 14,811 | Feb 17, 2023, 09:34 PM |
| Marshall Keith W | Chief Financial Officer | Feb 15, 2023 | Sale | $119.38 | 5,000 | 596,900 | 9,811 | Feb 17, 2023, 09:34 PM |
| McKenna Mark C. | Chairman, President & CEO | Feb 16, 2023 | Option Exercise | $3.70 | 25,000 | 92,500 | 80,144 | Feb 17, 2023, 09:31 PM |
| McKenna Mark C. | Chairman, President & CEO | Feb 15, 2023 | Option Exercise | $2.90 | 25,000 | 72,500 | 80,144 | Feb 17, 2023, 09:31 PM |
| McKenna Mark C. | Chairman, President & CEO | Feb 17, 2023 | Option Exercise | $3.70 | 13,680 | 50,616 | 68,824 | Feb 17, 2023, 09:31 PM |
| McKenna Mark C. | Chairman, President & CEO | Feb 15, 2023 | Sale | $119.42 | 25,000 | 2,985,500 | 55,144 | Feb 17, 2023, 09:31 PM |
| McKenna Mark C. | Chairman, President & CEO | Feb 17, 2023 | Sale | $125.10 | 13,680 | 1,711,368 | 55,144 | Feb 17, 2023, 09:31 PM |
| McKenna Mark C. | Chairman, President & CEO | Feb 16, 2023 | Sale | $119.87 | 25,000 | 2,996,750 | 55,144 | Feb 17, 2023, 09:31 PM |
| Marshall Keith W | Chief Financial Officer | Jan 17, 2023 | Option Exercise | $3.70 | 5,000 | 18,500 | 14,811 | Jan 19, 2023, 08:42 PM |
| Marshall Keith W | Chief Financial Officer | Jan 17, 2023 | Sale | $119.00 | 5,000 | 595,000 | 9,811 | Jan 19, 2023, 08:42 PM |
| McKenna Mark C. | Chairman, President & CEO | Jan 17, 2023 | Option Exercise | $2.90 | 25,000 | 72,500 | 80,144 | Jan 19, 2023, 08:39 PM |
| McKenna Mark C. | Chairman, President & CEO | Jan 17, 2023 | Sale | $118.99 | 25,000 | 2,974,750 | 55,144 | Jan 19, 2023, 08:39 PM |
| McKenna Mark C. | Chairman, President & CEO | Dec 01, 2021 | Option Exercise | $2.90 | 15,400 | 44,660 | 15,400 | Dec 03, 2021, 07:02 PM |
| Cormorant Asset Management, LP | Former 10% Owner | Mar 16, 2021 | Buy | $19.00 | 375,000 | 7,125,000 | 2,223,022 | Mar 18, 2021, 04:43 PM |
| Point72 Biotech Private Investments, LLC | Former 10% Owner | Mar 16, 2021 | Buy | $19.00 | 800,000 | 15,200,000 | 2,648,024 | Mar 17, 2021, 07:47 PM |
| Stenhouse Mark | Chief Operating Officer | Mar 16, 2021 | Buy | $19.00 | 14,000 | 266,000 | 14,000 | Mar 16, 2021, 09:49 PM |
| PAPA JOSEPH C | Director | Mar 16, 2021 | Buy | $19.00 | 15,000 | 285,000 | 15,000 | Mar 16, 2021, 09:48 PM |
| Adams Helen C. | Director | Mar 16, 2021 | Buy | $19.00 | 500 | 9,500 | 500 | Mar 16, 2021, 09:47 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Mar 16, 2021 | Buy | $19.00 | 850,000 | 16,150,000 | 3,314,032 | Mar 16, 2021, 08:30 PM |
| RTW INVESTMENTS, LP | 10% Owner | Mar 16, 2021 | Buy | $19.00 | 800,000 | 15,200,000 | 800,000 | Mar 16, 2021, 07:57 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| McKenna Mark C. | Chairman, President & CEO | 06/02/2023 | 355,336 |
| Marshall Keith W | Chief Financial Officer | 06/02/2023 | 242,302 |
| Marshall Keith W | Chief Financial Officer | 04/05/2023 | 37,000 |
| Marshall Keith W | Chief Financial Officer | 04/05/2023 | 1,084,200 |
| McKenna Mark C. | Chairman, President & CEO | 03/15/2023 | 72,500 |
| McKenna Mark C. | Chairman, President & CEO | 03/15/2023 | 2,903,500 |
| Marshall Keith W | Chief Financial Officer | 03/06/2023 | 37,000 |
| Marshall Keith W | Chief Financial Officer | 03/06/2023 | 1,221,300 |
| Cedars Sinai Intellectual Property Co | 10% Owner | 03/08/2023 | 99,120,347 |
| McKenna Mark C. | Chairman, President & CEO | 03/03/2023 | 39,294 |
| McKenna Mark C. | Chairman, President & CEO | 03/01/2023 | 2,590 |
| McKenna Mark C. | Chairman, President & CEO | 03/03/2023 | 1,328,881 |
| McKenna Mark C. | Chairman, President & CEO | 03/01/2023 | 87,682 |
| Marshall Keith W | Chief Financial Officer | 02/15/2023 | 18,500 |
| Marshall Keith W | Chief Financial Officer | 02/15/2023 | 596,900 |
| McKenna Mark C. | Chairman, President & CEO | 02/16/2023 | 92,500 |
| McKenna Mark C. | Chairman, President & CEO | 02/15/2023 | 72,500 |
| McKenna Mark C. | Chairman, President & CEO | 02/17/2023 | 50,616 |
| McKenna Mark C. | Chairman, President & CEO | 02/15/2023 | 2,985,500 |
| McKenna Mark C. | Chairman, President & CEO | 02/17/2023 | 1,711,368 |
| McKenna Mark C. | Chairman, President & CEO | 02/16/2023 | 2,996,750 |
| Marshall Keith W | Chief Financial Officer | 01/17/2023 | 18,500 |
| Marshall Keith W | Chief Financial Officer | 01/17/2023 | 595,000 |
| McKenna Mark C. | Chairman, President & CEO | 01/17/2023 | 72,500 |
| McKenna Mark C. | Chairman, President & CEO | 01/17/2023 | 2,974,750 |
| McKenna Mark C. | Chairman, President & CEO | 12/01/2021 | 44,660 |
| Cormorant Asset Management, LP | Former 10% Owner | 03/16/2021 | 7,125,000 |
| Point72 Biotech Private Investments, LLC | Former 10% Owner | 03/16/2021 | 15,200,000 |
| Stenhouse Mark | Chief Operating Officer | 03/16/2021 | 266,000 |
| PAPA JOSEPH C | Director | 03/16/2021 | 285,000 |
| Adams Helen C. | Director | 03/16/2021 | 9,500 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 03/16/2021 | 16,150,000 |
| RTW INVESTMENTS, LP | 10% Owner | 03/16/2021 | 15,200,000 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR PROMETHEUS BIOSCIENCES INC
STOCK BUYBACKS FOR PROMETHEUS BIOSCIENCES INC
Load More
Period of Report: 03/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2022
10.44%
1Q
09/30/2022
15.15%
2Q
06/30/2022
20.94%
3Q
03/31/2022
21.67%
4Q
09/30/2021
22.17%
6Q
06/30/2021
22.28%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PROMETHEUS BIOSCIENCES INC
LOADING...